These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21762077)

  • 1. A systems pharmacology analysis of major chemotherapy combination regimens used in gastric cancer treatment: predicting potential new protein targets and drugs.
    Rosado JO; Henriques JP; Bonatto D
    Curr Cancer Drug Targets; 2011 Sep; 11(7):849-69. PubMed ID: 21762077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y; Hui H; Wang X; Wu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for second-line chemotherapy in advanced gastric cancer?
    Wesolowski R; Lee C; Kim R
    Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of adjuvant chemotherapy for gastric cancer.
    Nakajima T
    World J Surg; 1995; 19(4):570-4. PubMed ID: 7676702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GRP78 expression in gastric cancer and its clinical significance].
    Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
    Farhat FS; Kattan J; Ghosn MG
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-operative groups in the development of chemotherapy for gastric cancer.
    Arai H; Sunakawa Y; Nakajima TE
    Jpn J Clin Oncol; 2019 Mar; 49(3):210-227. PubMed ID: 30508188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic overview of chemotherapy effects in gastric cancer.
    Janunger KG; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of precautionary chemotherapy in gastric cancer].
    Rimassa L; Campagnoli E; Biancofiore G
    Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Resistance to Chemotherapy in Gastric Cancer.
    Marin JJ; Al-Abdulla R; Lozano E; Briz O; Bujanda L; Banales JM; Macias RI
    Anticancer Agents Med Chem; 2016; 16(3):318-34. PubMed ID: 26234359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and stomach cancer.
    Toffoli G; Cecchin E
    Pharmacogenomics; 2004 Sep; 5(6):627-41. PubMed ID: 15335285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of chemotherapy for metastatic gastric cancer.
    O'Brien ME; Cunningham D
    J Infus Chemother; 1995; 5(3):112-6. PubMed ID: 8528967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
    J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced gastric cancer: present status, future prospects.
    Macdonald JS; Gohmann JJ
    Semin Oncol; 1988 Jun; 15(3 Suppl 4):42-9. PubMed ID: 3293218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.